XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Condensed Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Income Statement [Abstract]        
Net sales and revenue $ 221,079 $ 220,277 $ 645,770 $ 654,833
Cost of sales (includes $32,723 and $35,155 with related parties for the quarters ended October 31, 2023 and 2022, respectively, and $92,610 and $101,240 with related parties for the nine months ended October 31, 2023 and 2022, respectively) 181,789 211,004 577,962 619,549
Gross profit 39,290 9,273 67,808 35,284
Selling, general and administrative expenses (7,609) (5,823) (21,996) (17,689)
Equity in income of unconsolidated affiliates 4,738 661 9,275 6,210
Interest and other income, net 4,863 1,983 10,935 10,338
Income before income taxes 41,282 6,094 66,022 34,143
Provision for income taxes (9,640) (1,196) (15,396) (7,374)
Net income 31,642 4,898 50,626 26,769
Net income attributable to noncontrolling interests (5,566) (1,714) (10,259) (7,233)
Net income attributable to REX common shareholders $ 26,076 $ 3,184 $ 40,367 $ 19,536
Weighted average shares outstanding – basic and diluted (in Shares) 17,531 17,591 17,461 17,714
Basic and diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 1.49 $ 0.18 $ 2.31 $ 1.1